Bronchiectasis: Breaking the cycle of inflammation and infection

The Lancet Respiratory Medicine

Volumn 1, Issue 1, 2013, Pages

  Mandal, Pallavi ^a   Hill, Adam T ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZITHROMYCIN; BRONCHODILATING AGENT; CIPROFLOXACIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GENTAMICIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MACROLIDE; MYELOPEROXIDASE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; BACTERIAL LOAD; BRONCHIECTASIS; BRONCHITIS; BRONCHOSPASM; COLONY FORMING UNIT; DISEASE CLEARANCE; DISEASE EXACERBATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; QUALITY OF LIFE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; COMPLICATION; INFLAMMATION; RESPIRATORY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BRONCHIECTASIS; HUMANS; INFLAMMATION; RESPIRATORY TRACT INFECTIONS;

EID: 84880039492     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70005-5     Document Type: Note

References (7)

1. Hill AT, Welham S, Reid K, Bucknall CE British Thoracic Society. British Thoracic Society national bronchiectasis audit 2010 and 2011. Thorax 2012, 67:928-930.
2. Quality standards for clinically significant bronchiectasis in adults British Thoracic Society, (accessed Dec 10, 2012). http://www.brit-thoracic.org.uk/Portals/0/Guidelines/Bronchiectasis/244457_BTS_Quality_Standards_Bronchiectasis.pdf.
3. Davies RJ, Cole PJ A new look at the pathogenesis and management of persistent bronchial sepsis: a " vicious circle" hypothesis and its logical therapeutic connotations. Strategies for the management of bronchial sepsis 1984, Medicine Publishing Foundation, Oxford. R.J. Davies (Ed.).
4. Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2012, 186:657-665.
5. Wilson R, Welte T, Polverino E, et al. Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a phase II randomised study. Eur Respir J 2012, published online Sept 27. 10.1183/09031936.00071312.
6. Murray MP, Govan JR, Doherty CJ, et al. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010, 183:449-491.
7. Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012, 380:660-667.